Enhanced defense against Pneumocystis carinii mediated by a novel dectin-1 receptor Fc fusion protein

Journal of Immunology

Volumn 178, Issue 6, 2007, Pages 3702-3712

  Rapaka, Rekha M ^a,b   Goetzman, Eric S ^a   Zheng, Mingquan ^a   Vockley, Jerry ^a   McKinley, Laura ^a   Kolls, Jay K ^a,b   Steele, Chad ^a,b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA 1,3 GLUCAN; DECTIN 1; FC RECEPTOR; HYBRID PROTEIN; IMMUNOGLOBULIN G1; PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CORRELATION ANALYSIS; HOST RESISTANCE; LUNG ALVEOLUS MACROPHAGE; MALE; MOUSE; NONHUMAN; OPSONIZATION; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; PROTEIN DOMAIN; SCID MOUSE;

EID: 33947193437     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.6.3702     Document Type: Article

References (73)

1. Morris, A., J. D. Lundgren, H. Masur, P. D. Walzer, D. L. Hanson, T. Frederick, L. Huang, C. B. Beard, and J. E. Kaplan. 2004. Current epidemiology of Pneumocystis pneumonia. Emerg. Infect. Dis. 10: 1713-1720.
2. Fisk, D. T., S. Meshnick, and P. H. Kazanjian. 2003. Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin. Infect. Dis. 36: 70-78.
3. Severe, P., P. Leger, M. Charles, F. Noel, G. Bonhomme, G. Bois, E. George, S. Kenel-Pierre, P. F. Wright, R. Gulick, et al. 2005. Antiretroviral therapy in a thousand patients with AIDS in Haiti. N. Engl. J. Med. 353: 2325-2334.
4. Bakeera-Kitaka, S., P. Musoke, R. Downing, and J. K. Tumwine. 2004. Pneumocystis carinii in children with severe pneumonia at Mulago Hospital, Uganda. Ann. Trop. Paediatr. 24: 227-235.
5. Murray, J. F. 2005. Pulmonary complications of HIV-1 infection among adults living in sub-Saharan Africa. Int. J. Tuberc. Lung. Dis. 9: 826-835.
6. Graham, S. M. 2005. Non-tuberculosis opportunistic infections and other lung diseases in HIV-infected infants and children. Int. J. Tuberc. Lung Dis. 9: 592-602.
7. Crothers, K., C. B. Beard, J. Turner, G. Groner, M. Fox, A. Morris, S. Eiser, and L. Huang. 2005. Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. AIDS 19: 801-805.
8. Shellito, J., V. V. Suzara, W. Blumenfeld, J. M. Beck, H. J. Steger, and T. H. Ermak. 1990. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J. Clin. Invest. 85: 1686-1693.
9. Wiley, J. A., and A. G. Harmsen. 1995. CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. J. Immunol. 155: 3525-3529.
10. Marcotte, H., D. Levesque, K. Delanay, A. Bourgeault, R. de la Durantaye, S. Brochu, and M. C. Lavoie. 1996. Pneumocystis carinii infection in transgenic B cell-deficient mice. J. Infect. Dis. 173: 1034-1037.
11. Gigliotti, F., C. G. Haidaris, T. W. Wright, and A. G. Harmsen. 2002. Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia. Infect. Immun. 70: 1069-1074.
12. + T cell-independent vaccination against Pneumocystis carinii in mice. J. Clin. Invest. 108: 1469-1474.
13. Roths, J. B., and C. L. Sidman. 1993. Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice. Infect. Immun. 61: 1641-1649.
14. Harmsen, A. G., W. Chen, and F. Gigliotti. 1995. Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice. Infect. Immun. 63: 2391-2395.
15. + αβ T lymphocytes. Eur. J. Immunol. 29: 2464-2475.
16. Steele, C., L. Marrero, S. Swain, A. G. Harmsen, M. Zheng, G. D. Brown, S. Gordon, J. E. Shellito, and J. K. Kolls. 2003. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 β-glucan receptor. J. Exp. Med. 198: 1677-1688.
17. + T cell-independent DNA vaccination against opportunistic infections. J. Clin. Invest. 115: 3536-3544.
18. Lund, F. E., K. Schuer, M. Hollifield, T. D. Randall, and B. A. Garvy. 2003. Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P. carinii-specific antibody. J. Immunol. 171: 1423-1430.
19. Angus, C. W., A. Tu, P. Vogel, M. Qin, and J. A. Kovacs. 1996. Expression of variants of the major surface glycoprotein of Pneumocystis carinii. J. Exp. Med. 183: 1229-1234.
20. Lee, L. H., F. Gigliotti, T. W. Wright, P. J. Simpson-Haidaris, G. A. Weinberg, and C. G. Haidaris. 2000. Molecular characterization of KEX1, a kexin-like protease in mouse Pneumocystis carinii. Gene 242: 141-150.
21. Peppel, K., D. Crawford, and B. Beutler. 1991. A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J. Exp. Med. 174: 1483-1489.
22. Kolls, J., K. Peppel, M. Silva, and B. Beutler. 1994. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 91: 215-219.
23. Ariizumi, K., G. L. Shen, S. Shikano, S. Xu, R. Ritter III, T. Kumamoto, D. Edelbaum, A. Morita, P. R. Bergstresser, and A. Takashima. 2000. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J. Biol. Chem. 275: 20157-20167.
24. + T cells. J. Immunol. 162: 2890-2894.
25. Brown, G. D., P. R. Taylor, D. M. Reid, J. A. Willment, D. L. Williams, L. Martinez-Pomares, S. Y. Wong, and S. Gordon. 2002. Dectin-1 is a major β-glucan receptor on macrophages. J. Exp. Med. 196: 407-412.
26. + T cells. Infect. Immun. 70: 5208-5215.
27. Matsumoto, Y., S. Matsuda, and T. Tegoshi. 1989. Yeast glucan in the cyst wall of Pneumocystis carinii. J. Protozool. 36: 21S-22S.
28. Read, S. M., G. Currie, and A. Bacic. 1996. Analysis of the structural heterogeneity of laminarin by electrospray-ionisation-mass spectrometry. Carbohydr. Res. 281: 187-201.
29. Cabib, E., S. J. Silverman, A. Shaw, S. Das Gupta, H. M. Park, J. Thomas-Mullins, P. C. Mol, and B. Bowers. 1991. Carbohydrates as structural constituents of yeast cell wall and septum. Pure Appl. Chem. 63: 483-489.
30. Brown, G. D., and S. Gordon. 2001. Immune recognition: a new receptor for β-glucans. Nature 413: 36-37.
31. Galustian, C., C. G. Park, W. Chai, M. Kiso, S. A. Bruening, Y. S. Kang, R. M. Steinman, and T. Feizi. 2004. High and low affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin. Int. Immunol. 16: 853-866.
32. Wild, M. K., M. C. Huang, U. Schulze-Horsel, P. A. van der Merwe, and D. Vestweber. 2001. Affinity, kinetics, and thermodynamics of E-selectin binding to E-selectin ligand-1. J. Biol. Chem. 276: 31602-31612.
33. Muller-Loennies, S., S. Gronow, L. Brade, R. MacKenzie, P. Kosma, and H. Brade. 2006. A monoclonal antibody against a carbohydrate epitope in lipopolysaccharide differentiates Chlamydophila psittaci from Chlamydophila pecorum, Chlamydophila pneumoniae, and Chlamydia trachomatis. Glycobiology 16: 184-196.
34. Vyas, N. K., M. N. Vyas, M. C. Chervenak, D. R. Bundle, B. M. Pinto, and F. A. Quiocho. 2003. Structural basis of peptide-carbohydrate mimicry in an antibody-combining site. Proc. Natl. Acad. Sci. USA 100: 15023-15028.
35. Garcia-Ojeda, P. A., S. Hardy, S. Kozlowski, K. E. Stein, and I. M. Feavers. 2004. Surface plasmon resonance analysis of antipolysaccharide antibody specificity: responses to meningococcal group C conjugate vaccines and bacteria. Infect. Immun. 72: 3451-3460.
36. Di Carlo, F. J., and J. V. Fiore. 1958. On the composition of zymosan. Science 127: 756-757.
37. Nimmerjahn, F., and J. V. Ravetch. 2006. Fcγ receptors: old friends and new family members. Immunity 24: 19-28.
38. Roth, A., J. Wecke, V. Karsten, and K. Janitschke. 1997. Light and electron microscopy study of carbohydrate antigens found in the electron-lucent layer of Pneumocystis carinii cysts. Parasitol. Res. 83: 177-184.
39. Hahn, P. Y., S. E. Evans, T. J. Kottom, J. E. Standing, R. E. Pagano, and A. H. Limper. 2003. Pneumocystis carinii cell wall β-glucan induces release of macrophage inflammatory protein-2 from alveolar epithelial cells via a lactosyl-ceramide-mediated mechanism. J. Biol. Chem. 278: 2043-2050.
40. + T cells: role of granulocyte-macrophage colony-stimulating factor. Infect. Immun. 73: 7450-7457.
41. Sehra, S., G. Pynaert, K. Tournoy, A. Haegeman, P. Matthys, Y. Tagawa, R. Pauwels, and J. Grooten. 2003. Airway IgG counteracts specific and bystander allergen-triggered pulmonary inflammation by a mechanism dependent on FcγR and IFN-γ. J. Immunol. 171: 2080-2089.
42. Kolls, J. K., D. Lei, S. Nelson, W. R. Summer, S. Greenberg, and B. Beutler. 1995. Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary host defense. J. Infect. Dis. 171: 570-575.
43. Kolls, J. K., D. Lei, G. Odom, S. Nelson, W. R. Summer, M. A. Gerber, and J. E. Shellito. 1996. Use of transient CD4 lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors. Hum. Gene Ther. 7: 489-497.
44. Spiekermann, G. M., P. W. Finn, E. S. Ward, J. Dumont, B. L. Dickinson, R. S. Blumberg, and W. I. Lencer. 2002. Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung. J. Exp. Med. 196: 303-310.
45. Meissner, N. N., F. E. Lund, S. Han, and A. Harmsen. 2005. CD8 T cell-mediated lung damage in response to the extracellular pathogen pneumocystis is dependent on MHC class I expression by radiation-resistant lung cells. J. Immunol. 175: 8271-8279.
46. Wright, T. W., F. Gigliotti, J. N. Finkelstein, J. T. McBride, C. L. An, and A. G. Harmsen. 1999. Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. J. Clin. Invest. 104: 1307-1317.
47. Chen, W., J. W. Mills, and A. G. Harmsen. 1992. Development and resolution of Pneumocystis carinii pneumonia in severe combined immunodeficient mice: a morphological study of host inflammatory responses. Int. J. Exp. Pathol. 73: 709-720.
48. Mason, G. R., C. H. Hashimoto, P. S. Dickman, L. F. Foutty, and C. J. Cobb. 1989. Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS. Am. Rev. Respir. Dis. 139: 1336-1342.
49. Thomas, C. F., Jr., and A. H. Limper. 2004. Pneumocystis pneumonia. N. Engl. J. Med. 350: 2487-2498.
50. Hoffman, O. A., J. E. Standing, and A. H. Limper. 1993. Pneumocystis carinii stimulates tumor necrosis factor-α release from alveolar macrophages through a β-glucan-mediated mechanism. J. Immunol. 150: 3932-3940.
51. Gantner, B. N., R. M. Simmons, and D. M. Underhill. 2005. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J. 24: 1277-1286.
52. Netea, M. G., N. A. Gow, C. A. Munro, S. Bates, C. Collins, G. Ferwerda, R. P. Hobson, G. Bertram, H. B. Hughes, T. Jansen, et al. 2006. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J. Clin. Invest. 116: 1642-1650.
53. Steele, C., R. R. Rapaka, A. Metz, S. M. Pop, D. L. Williams, S. Gordon, J. K. Kolls, and G. D. Brown. 2005. The β-glucan receptor Dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog. 1: e42.
54. Hohl, T. M., H. L. Van Epps, A. Rivera, L. A. Morgan, P. L. Chen, M. Feldmesser, and E. G. Pamer. 2005. Aspergillus fumigatus triggers inflammatory responses by stage-specific β-glucan display. PLoS Pathog. 1: e30.
55. Viriyakosol, S., J. Fierer, G. D. Brown, and T. N. Kirkland. 2005. Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on Toll-like receptor 2 and Dectin-1. Infect. Immun. 73: 1553-1560.
56. Saijo, S., N. Fujikado, T. Furuta, S. H. Chung, H. Kotaki, K. Seki, K. Sudo, S. Akira, Y. Adachi, N. Ohno, et al. 2006. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol. 8: 39-46.
57. Taylor, P. R., S. V. Tsoni, J. A. Willment, K. M. Dennehy, M. Rosas, H. Findon, K. Haynes, C. Steele, M. Botto, S. Gordon, and G. D. Brown. 2006. Dectin-1 is required for β-glucan recognition and control of fungal infection. Nat Immunol. 8: 31-38.
58. Hohl, T. M., and E. G. Pamer. 2006. Cracking the fungal armor. Nat. Med. 12, 730-732.
59. Kottom, T. J., and A. H. Limper. 2000. Cell wall assembly by Pneumocystis carinii: evidence for a unique gsc-1 subunit mediating β-1,3-glucan deposition. J. Biol. Chem. 275: 40628-40634.
60. Bartlett, M. S., W. L. Current, M. P. Goheen, C. J. Boylan, C. H. Lee, M. M. Shaw, S. F. Queener, and J. W. Smith. 1996. Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo. Antimicrob. Agents Chemother. 40: 1811-1816.
61. Schmatz, D. M., M. A. Romancheck, L. A. Pittarelli, R. E. Schwartz, R. A. Fromtling, K. H. Nollstadt, F. L. Vanmiddlesworth, K. E. Wilson, and M. J. Turner. 1990. Treatment of Pneumocystis carinii pneumonia with 1,3-β-glucan synthesis inhibitors. Proc. Natl. Acad. Sci. USA 87: 5950-5954.
62. Beck, J. M., M. B. Blackmon, C. M. Rose, S. L. Kimzey, A. M. Preston, and J. M. Green. 2003. T cell costimulatory molecule function determines susceptibility to infection with Pneumocystis carinii in mice. J. Immunol. 171: 1969-1977.
63. Gantner, B. N., R. M. Simmons, S. J. Canavera, S. Akira, and D. M. Underhill. 2003. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197: 1107-1117.
64. Limper, A. H., J. S. Hoyte, and J. E. Standing. 1997. The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. J. Clin. Invest. 99: 2110-2117.
65. Lasbury, M. E., P. J. Durant, C. A. Ray, D. Tschang, R. Schwendener, and C. H. Lee. 2006. Suppression of alveolar macrophage apoptosis prolongs survival of rats and mice with Pneumocystis pneumonia. J. Immunol. 176: 6443-6453.
66. Yasuoka, A., N. Tachikawa, K. Shimada, S. Kimura, and S. Oka. 1996. (1→3) β-D-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia. Clin. Diagn. Lab. Immunol. 3: 197-199.
67. Allen, M. J., A. Laederach, P. J. Reilly, and R. J. Mason. 2001. Polysaccharide recognition by surfactant protein D: novel interactions of a C-type lectin with nonterminal glucosyl residues. Biochemistry 40: 7789-7798.
68. Yong, S. J., Z. Vuk-Pavlovic, J. E. Standing, E. C. Crouch, and A. H. Limper. 2003. Surfactant protein D-mediated aggregation of Pneumocystis carinii impairs phagocytosis by alveolar macrophages. Infect. Immun. 71: 1662-1671.
69. Atochina, E. N., A. J. Gow, J. M. Beck, A. Haczku, A. Inch, H. Kadire, Y. Tomer, C. Davis, A. M. Preston, F. Poulain, et al. 2004. Delayed clearance of Pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice. J. Infect. Dis. 189: 1528-1539.
70. Zhang, M. X., D. M. Lupan, and T. R. Kozel. 1997. Mannan-specific immunoglobulin G antibodies in normal human serum mediate classical pathway initia-tion of C3 binding to Candida albicans. Infect. Immun. 65: 3822-3827.
71. Zhang, M. X., and T. R. Kozel. 1998. Mannan-specific immunoglobulin G antibodies in normal human serum accelerate binding of C3 to Candida albicans via the alternative complement pathway. Infect. Immun. 66: 4845-4850.
72. Stehle, S. E., R. A. Rogers, A. G. Harmsen, and R. A. Ezekowitz. 2000. A soluble mannose receptor immunoadhesin enhances phagocytosis of Pneumocystis carinii by human polymorphonuclear leukocytes in vitro. Scand. J. Immunol. 52: 131-137.
73. Torosantucci, A., C. Bromuro, P. Chiani, F. De Bernardis, F. Berti, C. Galli, F. Norelli, C. Bellucci, L. Polonelli, P. Costantino, et al. 2005. A novel glycoconjugate vaccine against fungal pathogens. J. Exp. Med. 202: 597-606.